Sicagen India (BOM:533014) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533014 Sicagen India Ltd BOM:533014
71 GF Score
Price ₹56.12
GF Value ₹79.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sicagen India Marketable Securities?

Sicagen India BOM:533014 +1.12% 71 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:533014 with a GF Score™ of 71/100 and a GF Value™ of ₹79.21 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sicagen India's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Sicagen India's annual Marketable Securities increased from Mar. 2024 (₹314 Mil) to Mar. 2025 (₹514 Mil) and increased from Mar. 2025 (₹514 Mil) to Mar. 2026 (₹667 Mil).

Sicagen India  (BOM:533014) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sicagen India Marketable Securities Related Terms

Sicagen India Marketable Securities Historical Data

* Premium members only.

The historical data trend for Sicagen India's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sicagen India Marketable Securities Chart

Sicagen India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.60 185.60 314.30 513.90 666.50

Sicagen India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,357.80 0.00 666.50 0.00
BOM:533014
71GF Score
Sicagen India Ltd BOM:533014
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sicagen India Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Sicagen India (BOM:533014) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sicagen India and its competitors.
Is Sicagen India's Marketable Securities too high?
Sicagen India's current Marketable Securities is ₹0 Mil. Overall, Sicagen India has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sicagen India's Marketable Securities compare to NUE and STLD?
Sicagen India's Marketable Securities of ₹0 Mil can be compared against companies in the Steel industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Steel company?
A good Marketable Securities depends on the Steel industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sicagen India and its competitors. Sicagen India's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sicagen India stock overvalued right now?
Based on GuruFocus' analysis, Sicagen India (BOM:533014) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹79.21, compared to a current price of ₹56.12 — trading 29.2% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Sicagen India's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Sicagen India (BOM:533014), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sicagen India (BOM:533014) Overvalued in 2026?

Based on GuruFocus' analysis, Sicagen India stock appears to be undervalued. The current stock price of ₹56.12 is trading 29.2% below its estimated GF Value™ of ₹79.21. GuruFocus considers Sicagen India to be Modestly Undervalued.

Key valuation signals for BOM:533014:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹79.21 vs. price of ₹56.12 (29.2% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the BOM:533014 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sicagen India Business Description

Other Exchanges SICAGEN:India
Address No. 88, Mount Road, 4th Floor, SPIC House, Guindy, Chennai, TN, IND, 600 032
Sicagen India Ltd is an investment holding company. Its principal business lines are building materials, power and control systems, manufacturing of MS barrels and manufacturing of water treatment chemicals, industrial packaging, speciality chemicals, engineering, cable manufacturing, and fabrication. It serves a diverse range of markets including retail, institutional, dealers, corporate, builders, agriculturists, fabricators, and contractors. The company's segment includes Trading and Manufacturing. It generates maximum revenue from the Trading segment from India.
71GF Score

Get the complete analysis for BOM:533014

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹56.12
Price
₹79.21
GF Value